OPDUALAG
OPDUALAG
Approved
DIN Number
02541416
Drug Class
Human
Market Date
Feb 12, 2024
Company
HC
bristol-myers squibb canada
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02541416
AIG Number0264981001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
,
Schedule D
A
ATC Code
L01FY02 NIVOLUMAB AND RELATLIMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (2)
NIVOLUMABActive
Strength: 240 MG / 20 ML
Monograph: NIVOLUMAB
RELATLIMABActive
Strength: 80 MG / 20 ML
Monograph: RELATLIMAB